Hier werden die Unterschiede zwischen zwei Versionen angezeigt.
Beide Seiten der vorigen Revision Vorhergehende Überarbeitung Nächste Überarbeitung | Vorhergehende Überarbeitung Letzte Überarbeitung Beide Seiten der Revision | ||
argemone_mexicana_l [2014/09/11 19:16] andreas |
argemone_mexicana_l [2015/10/23 08:00] andreas |
||
---|---|---|---|
Zeile 1: | Zeile 1: | ||
- | Argemone mexicana L. - Papaveraceae | + | Argemone mexicana L. - Papaveraceae |
- | prickly poppy, Mexican poppy, **Mexikanischer Stachelmohn**, | + | |
Annual herb to 1m high, native to central America, cultivated for centuries, naturalized in many tropical | Annual herb to 1m high, native to central America, cultivated for centuries, naturalized in many tropical | ||
Zeile 17: | Zeile 16: | ||
[Argemone mexicana decoction for the treatment of uncomplicated falciparum malaria. Willcox, M. L., Graz, B., Falquet, J., Sidibé, O., Forster, M., Diallo, D., Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol.101(12), | [Argemone mexicana decoction for the treatment of uncomplicated falciparum malaria. Willcox, M. L., Graz, B., Falquet, J., Sidibé, O., Forster, M., Diallo, D., Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol.101(12), | ||
- | {{http:// | + | "We tested the malaria treatment Argemone mexicana decoction (AM), a validated self-prepared traditional medicine made with one widely available plant and safe across wide dose variations. In an attempt to reflect the real situation in the home-based management of malaria in a remote Malian village, 301 patients with presumed uncomplicated malaria (median age 5 years) were randomly assigned to receive AM or artesunate-amodiaquine [artemisinin combination therapy (ACT)] as first-line treatment. Both treatments were well tolerated. Over 28 days, second-line treatment was not required for 89% (95% CI 84.1-93.2) of patients on AM, versus 95% (95% CI 88.8-98.3) on ACT. Deterioration to severe malaria was 1.9% in both groups in children aged </=5 years (there were no cases in patients aged >5 years) and 0% had coma/convulsions. AM, now government-approved in Mali, could be tested as a first-line complement to standard modern drugs in high-transmission areas, in order to reduce the drug pressure for development of resistance to ACT, in the management of malaria. In view of the low rate of severe malaria and good tolerability, |
+ | [Argemone mexicana decoction versus artesunate-amodiaquine for the management of malaria in Mali: policy and public-health implications. Graz, B., Willcox, M. L., Diakite, C., Falquet, J., Dackuo, F., Sidibe, O., Diallo, D., Transactions of the Royal Society of Tropical Medicine and Hygiene, Vol.104(1), 2010, 33] | ||
+ | |||
+ | {{: | ||
+ | Millspaugh, | ||
+ | [[http:// |